United Therapeutics Corp at JPMorgan NAPA Valley Forum (Virtual) Transcript
Okay. Great. Good afternoon, everyone. My name is Jessica Fye. I'm the senior biotech analyst at JPMorgan. And we're continuing the Virtual Napa Valley Biotech Forum with United Therapeutic. I'm joined by the company's Chief Medical Officer, Dr. Gil Golden, and I think this is his first time in front of investors in a venue like this. So I think it's going to be great to get some more insight into the kind of medical point of view on the business. I also want to remind you guys to use the ask a question button on your screen to send me questions, there's a little lag, so just keep them coming, and we'll get to those.
Before we get started, I do want to pass it over to Dewey Steadman from IR to cover some of the legal logistics.
Good afternoon, everyone. Today's presentation may include forward-looking statements. And we encourage you to visit our SEC filings for the latest risks and uncertainties related to those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |